Condition
Post-Lung Transplantation Bronchiectasis
Total Trials
2
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting2
Clinical Trials (2)
Showing 2 of 2 trials
NCT04582279Not ApplicableRecruitingPrimary
Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients
NCT04783155Not ApplicableRecruitingPrimary
Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant
Showing all 2 trials